Vertex Pharma (VRTX) Tops Q3 EPS by 30c, Revenues Beat

Go back to Vertex Pharma (VRTX) Tops Q3 EPS by 30c, Revenues Beat

UPDATE: Vertex (VRTX) Initiated at Buy at UBS

October 27, 2020 4:50 PM EDT

(Updated - October 27, 2020 5:02 PM EDT)

UBS analyst Colin Bristow starts Vertex (NASDAQ: VRTX) at Buy, PT $287.00

... More